Most AI in Pharma Stops at Discovery
Over 80% of pharma AI startups focus on early-stage drug discovery—target identification, molecule generation, and screening.
But the rest of the value chain remains largely untouched.
A New Era with GenAI
With GenAI, pharma’s most complex, human-intensive processes can finally be transformed.
The next wave of pharmaceutical innovation won’t be in the lab -
it will be in the knowledge layer.
